Helping Innovative Small Businesses in Pennsylvania Win Federal Funding.

The Innovation Partnership (IPart) is a statewide consortium of economic development, business assistance, and higher education organizations that provide early-stage technology companies with free proposal writing assistance, training, and financial assistance. The goal: Help Pennsylvania-based clients secure federal funding opportunities – Specifically, SBIR/STTR.

16 Years of Proven Results

0

Sbir Proposals Submitted

  • Sbir
  • Awards
  • Received
0

Sbir Award Value to Date

$0 Million

  • Phase I:$17.4M
  • Phase II:$19.4M
0
Travel & Training Awards
IPart Awards to Clients (MG/MV/FMA)
0

Totalling

$0

Submission

Win

Rate

0%

(Compared to National Avarage of between 14% - 17%)

The Power of Partnership

Success Stories

IPart is a tremendous asset to that entrepreneur who needs not only proposal funding but critical feedback for devising a winning SBIR proposal!

- Jorgen Penderson, RE 2 Robotics

The SBIR process is very challenging. IPart assistance can be invaluable to a vast majority of tech companies looking to submit well-prepared proposals for SBIR/STTR funding.

- Liz Brensinger, Green Heron Tools

It’s great that Pennsylvania has a program like the Innovation Partnership. It helps technology companies with the SBIR process and win these very important grant awards to move their companies forward.

- Bo Liang, Adesso Advanced Materials Inc.

The programs, assistance and advice the IPart provides helped us significantly in our proposal improvement and to ultimately win a Phase I STTR from the NSF.

- Kamrun Nahar, Impulse Technology

IPart’s peer review and funding for grant-writing assistance were extremely helpful in strengthening our federal submission and winning the award.

Jamin Steffen, Hepron Molecular Lab, Inc.

IPart’s pre-review technical feedback, demand for early proposal preparation, and Travel & Training funding greatly benefitted our company’s ability to secure the SBIR grant funding.

-Surbhi Jain, JBS Science Inc.

The IPart’s $3,000 MicroVoucher for grant-writing assistance is very helpful for the technology companies applying for these federal grants – while it seems like a small amount – we can use all of the help we can get.

Matt Handle, Skyran Biologics, Inc.

I think the IPART program is a vital component of the startup ecosystem in the Pittsburgh area. It provides an opportunity for non-academics and academics with limited grant writing experience to construct competitive federal grants to secure seed funding.

- Sanna Gaspard, Rubitection

Solicitations dates

See More
Agency/ProgramRelease DateOpen DateClose DateIPart Deadline
DOD SBIR 20.3 BAA
DOD STTR 20.C BAA
Pre-Release
8/25/20
9/23/202010/22/2020Thurs 9/24/20
DOD-DARPA SBIR HR001120S0019 BAA
DOD-DARPA STTR HR001120S0019 BAA
Pre-Release
N/A
8/21/202012/31/2020Thurs 12/3/20
Department of Energy (DOE)
DOE SBIR/STTR FY2021
Phase 1 Release 1DE-FOA-0002359


FY 2021 SBIR/STTR Phase I
Release 1 Topics
8/24/20
LOI Due 9/8/20
5pm EST

LOI Due 9/8/20
5pm EST
10/19/2020
11:59PM EST
Mon 9/29/20
National Science Foundation (NSF)
(Project Pitch Required)
SBIR PhI 20527 STTR PhI 20528
COVID-19 Phase I Opportunities
NSF is offering fast turn-around time for COVID-19
related innovations
READ MORE HERE
12/18/193/6/203/6/20-6/4/20
6/5/20-9/3/20
9/4/20-12/3/20
(Submission Windows)

PPA 1st Draft
sent to IPart
6-5 weeks before
planned submission

PPA Submission
Deadline is
4 Weeks
before planned
federal submiss.
(rolling deadlines)>
USDA
USDA FY 2021
July 2020
July 202010/23/20Fri 9/25/20
EPA
EPA SBIR
June 2020
June 20208/28/20Fri 7/31/20
HHS (Health and Human Services) SBIR
Direct Phase II is reinstated until FY2022.
See individual SBIR solicitations.

New – Direct Phase II will be added as an allowable
Application Type either by Notice or in the solicitation in
Part II Section II if SBIR Direct Phase II will be accepted.

See the current list of Notices that have added Direct
Phase II to SBIR solicitations:http://bit.ly/2P0lm1H
7/14/20
7/14/209/5/20
1/5/21
4/5/21
Sat 8/8/20
Tues 12/8/20
Mon 3/8/21
HHS Omnibus (NIH)
Clinical Trails not allowed:
PA-20-260 SBIR-NIH, CDC & FDA
PA-20-265 STTR-NIH
Clinical Trials Required:
PA-20-262 SBIR-NIH
PA-20-261 STTR-NIH
2020 Program Descriptions & Research Topics Document
2020 SBA approved topics list for budget waivers

NIH SBIR/STTR GRANT FORMS

COVID-19 UPDATE - Check Notices of Special Interest
using search term "COVID" for competitive revision
opportunities
READ MORE
7/14/207/14/209/5/20
1/5/21
4/5/21
Sat 8/8/20
Tues 12/8/20
Mon 3/8/21